WallStreetZenWallStreetZen

NYSE: DNA
Ginkgo Bioworks Holdings Inc Stock Ownership - Who owns Ginkgo Bioworks Holdings?

Open Broker Account

Insider buying vs selling

Have Ginkgo Bioworks Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Marie E. FallonChief Accounting Officer2022-12-026,176$1.94
$12.00kSell
Christian O. HenryDirector2022-12-024,499$1.85
$8.32kSell
Mark E. DmytrukChief Financial Officer2022-12-0230,102$1.94
$58.49kSell
Reshma P. ShettyPresident COO Founder2022-12-01100,429$1.97
$198.05kSell
Jason R. KellyCEO Founder2022-12-01100,429$1.97
$198.05kSell
Barry Canton10% Owner2022-12-01100,429$1.97
$198.05kSell
Reshma P. ShettyPresident COO Founder2022-12-01100,429$1.97
$198.05kSell
Barry Canton10% Owner2022-12-01100,429$1.97
$198.05kSell
Barry Canton10% Owner2022-11-30102,676$1.79
$184.10kSell
Jason R. KellyCEO Founder2022-11-30102,676$1.79
$184.10kSell

1 of 19

DNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNA insiders and whales buy or sell their stock.

DNA Shareholders

What type of owners hold Ginkgo Bioworks Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baillie Gifford Co10.52%204,076,843$367.34MInstitution
Cascade Investment LLC7.83%151,865,481$273.36MInsider
Ark Investment Management LLC6.54%126,818,856$228.27MInstitution
Viking Global Investors LP5.25%101,834,126$183.30MInstitution
Vanguard Group Inc4.43%85,875,027$154.58MInstitution
Anchorage Capital Group LLC3.56%69,158,354$124.49MInstitution
Morgan Stanley2.80%54,244,005$97.64MInstitution
Viking Global Investors LP2.63%51,055,144$91.90MInsider
Barry Canton2.06%40,037,509$72.07MInsider
Reshma P. Shetty2.06%40,037,509$72.07MInsider

1 of 3

DNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNA45.10%17.85%Net SellingNet Selling
ZLAB5.94%1.95%Net SellingNet Buying
ABCL42.18%46.01%Net BuyingNet Buying
AXSM58.55%36.29%Net Buying
ARWR65.47%11.80%Net SellingNet Selling

Ginkgo Bioworks Holdings Stock Ownership FAQ

Who owns Ginkgo Bioworks Holdings?

Ginkgo Bioworks Holdings (NYSE: DNA) is owned by 45.10% institutional shareholders, 17.85% Ginkgo Bioworks Holdings insiders, and 37.05% retail investors. Cascade Investment LLC is the largest individual Ginkgo Bioworks Holdings shareholder, owning 151.87M shares representing 7.83% of the company. Cascade Investment LLC's Ginkgo Bioworks Holdings shares are currently valued at $259.69M.

If you're new to stock investing, here's how to buy Ginkgo Bioworks Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.